z-logo
Premium
Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa
Author(s) -
TasAygar Gamze,
Gonul Muzeyyen,
Ozcan Ibrahim,
Ayli Mehmet Deniz,
ErtoyBaydar Dilek
Publication year - 2020
Publication title -
dermatologic therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.14205
Subject(s) - hidradenitis suppurativa , secukinumab , medicine , amyloidosis , dermatology , aa amyloidosis , quality of life (healthcare) , psoriasis , disease , pathology , familial mediterranean fever , psoriatic arthritis , nursing
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here